A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 21, 2008

Lingering Side Effects Reported With Facial Filler

People who have injections of the facial filler polyalkylimide may have immune-related side effects many months after the injections, say the authors of a study published in the May 2008 issue of the Archives of Dermatology.

Though not approved in the United States, polyalkylimide—often sold as Bio-Alcamid in other countries—is a permanent filler that is a popular option for the treatment of HIV-associated facial lipoatrophy. Until now, there have not been reports of the immune system reacting to polyalkylimide.

Spanish physician Jaume Alijotas-Reig, MD, PhD, of the Vall d’Hebron University Hospital and Autonomous University of Barcelona, and his colleagues assessed 25 people who had what appeared to be side effects of polyalkylimide injections 12 months or more after treatment. The patients’ HIV statuses are not mentioned in the article.

Side effects ranged from tender nodules, or bumps, at the injection site in 24 of the patients, to more wide spread effects like headaches and fever in six people. Twenty people had laboratory abnormalities that implied immune inflammation. Side effects diminished and ultimately disappeared in 11 people over 21 months of follow-up.

Though it is impossible to determine from these case reports what proportion of people who receive polyalkylimide treatment will ultimately have these immune responses, they appear thus far to be a relatively rare phenomenon.

Search: polyalkylimide, Bio-Alcamid, Jaume Alijotas-Reig, Vall d'Hebron University, lipoatrophy, facial filler


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Lily, Spring, 2008-05-28 12:53:23
I would like to know why there are no studies out there going on with people/men/women/who are having fat changes throughout there body???? I know it is not a great amount, and there are newer drugs that do not cause fat waist/gain; however, what about the existing people that still do. And what about the ones that do not respond well??? Any thoughts......????

Nathaniel Johnson, cincinnati, 2008-05-28 10:29:00
I am a 20+ year survivor of HIV infection and live daily with the impact of facial wasting. I am a member of the AIDS Clinical Trials Group Network Community Advisory Board, the community voice in ACTG clinical trials. I do my best to keep the issue of side effects of current and past treatments on the radar screen because, just as this article documents, we have ongoing problems addressing the effects of facial wasting. I consider the high cost of the current options a barrier also.

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    dambitious
    Baltimore Co.
    Maryland


    Loveladyd
    Washington
    DC


    GeorgieBOOY
    Miami
    Florida


    cme_jamesd
    Huntington Beach
    California
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.